Description
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
| Product Unit Size | Cost | Quantity | Stock |
|---|
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
| Cas No. | 1700693-08-8 |
|---|---|
| Purity | ≥98% |
| Formula | C19H21ClN6O3 |
| Formula Wt. | 416.87 |
| IUPAC Name | (4-{[5-Chloro-4-(methylamino)-3H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone |
| Synonym | Pyrrolopyrimidine |
| Solubility | DMSO |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Hatcher J., Zhang J., et al. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 6(5):584-9 (2015). PMID: 26005538.
JAK1/2 inhibitor.
ERK1/2 inhibitor.
2-methyl-1,4-naphthoquinone derivative
HDAC1/2/3/11 inhibitor.
Endogenous peptide hormone, counteracts insulin...
Diacerein metabolite, anthraquinone found in Rh...
HDAC inhibitor.
EZH2 HMT inhibitor.
Semi-synthetic peptide, melanocortin analog; MC...
Bcl-2, Bcl-xl, sialyl transferase inhibitor.
Benzimidazole; microtubule polymerization inhib...
Neuroprotective flavonoid
Glutathione-S-transferase inhibitor.
NSAID; COX-1/2 and PDE inhibitor.
Protein synthesis inhibitor, used to measure pr...
Purine derivative; CDK inhibitor.
Potential voltage-gated Na+ channel blocker.
Synthetic antioxidant that induces phase II enz...
Kavalactone originally found in Piper methystic...
EGFR inhibitor.